Helsinn Investment Fund: Ten finalists have been chosen for the second annual Lyfebulb-Helsinn Innovation Summit & Awards in Oncology

    NEXT STORY
    Trident Brands, Brain Armor and NorthShore University HealthSystem Provide Update on Brain Health Research Collaboration
    PREV STORY
    Progressive Care Inc. Subsidiary PharmCo, LLC Earns Top Performance Scores From Humana Inc.
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Achillion Appoints Dr. Steven Zelenkofske as Chief Medical Officer and Further Strengthens Clinical Development Team

    NEW HAVEN, Conn., Aug. 21, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) ...

    author_avatar
    NASDAQ Market News

    Celsion Corporation Reports First Quarter 2017 Financial Results and Provides Business Update

    LAWRENCEVILLE, N.J., May 12, 2017 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ:CLSN), an oncology drug ...

    author_avatar
    NASDAQ Market News

    Radius Health & Menarini Group Provide Elacestrant Update

    author_avatar
    NASDAQ Market News